Robert H. Pierce

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Paul C. Tumeh, Christina L. Harview, Jennifer H. Yearley et al. · Nature · 2014 · 6.5K citations · Full text

Medicine, Immunology, Tumor Immunity +6

IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells

Jonathan Sherlock, Barbara Joyce-Shaikh, Scott Turner et al. · Nature Medicine · 2012 · 1K citations

Inflammation, Rheumatology, Autoimmune Disease +13

Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

Christopher Garris, Sean P. Arlauckas, Rainer H. Köhler et al. · Immunity · 2018 · 899 citations · Full text

Cancer Immunosurveillance, Immunology, Tumor Immunity +12

Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors

Amita Patnaik, Soonmo Peter Kang, Drew Rasco et al. · Clinical Cancer Research · 2015 · 767 citations

Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC

Paul C. Tumeh, Matthew D. Hellmann, Omid Hamid et al. · Cancer Immunology Research · 2017 · 543 citations · Full text